French President Emmanuel Macron delivers a speech as he visits the Laboratoire Aguettant pharmaceutical production plant in Champagne to talk about the health industry, in central France, Tuesday, June 13, 2023. (Eric Gaillard/Pool via AP)
June 15, 2023 12:34 PM EDTUpdated 02:13 PM
Manufacturing

France looks to boost its do­mes­tic sup­ply of drugs

Tyler Patchen

News Reporter

It is no se­cret that the US has been star­ing down short­ages of drugs rang­ing from an­tibi­otics such as amox­i­cillin to com­mon can­cer treat­ments, but …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

Eu­ro­pean drug reg­u­la­tor re­jects Alzheimer's drug Leqem­bi, cit­ing safe­ty con­cerns

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times